National Institute on Alcohol Abuse and Alcoholism, 2025)
Reduce the risk of kidney disease progression , kidney failure, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease (CKD) a new and notable expanded indication
By Product Type, the Oral Glutathione Formulations Segment Accounts for the Largest Market Share The oral glutathione segment holds a dominant 30% revenue share in 2025, driven by strong consumer preference for capsules, tablets, and powders that support intracellular antioxidant activity, immunity, and detoxification
4 Challenges and future directions 4.1 Safety considerations The safety profile of dual or triple receptor agonists targeting GLP-1, GIP, and GCG receptors in the treatment of MASLD and related metabolic disorders warrants careful evaluation
Pharmacodynamic effects of semorinemab on plasma and CSF biomarkers of Alzheimers disease pathophysiology
Potential Side Effects of Semaglutide Like all medications, semaglutide can cause side effects in some people
